Vidaza and acute pulmonary oedema Patient Reports March 22, 2010

Vidaza Side Effects Report #5449798-4
Vidaza side effect was reported by a Physician from ITALY on Aug 29, 2007. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, aspergillosis, blood pressure increased, cytomegalovirus infection , epstein-barr virus infection, heart rate increased, pneumocystis jiroveci pneumonia, urinary retention. Vidaza dosage: (140 MG, DAILY X 7). During the same period patient was treated with VALPROIC ACID. Patient was hospitalized. Patient died on 08/24/2007.

Vidaza Side Effects Report #5486003-7
Vidaza side effect was reported by a Physician from ITALY on Sept 28, 2007. Male patient, 72 years of age, weighting 158.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, aspergillosis, blood pressure increased, cytomegalovirus infection , epstein-barr virus infection, haemoglobin decreased, platelet count decreased, pneumocystis jiroveci pneumonia, urinary retention. Vidaza dosage: (140 MG, DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with VALPROIC ACID, BACTRIM, PREDNISONE, RABEPRAZOLE, FOSFAMICINA, TROMETAMOLO, CARVEDILOLO. Patient was hospitalized. Patient died on 08/24/2007.

Vidaza Side Effects Report #5902869-8
Vidaza side effect was reported by a Physician from AUSTRALIA on Sept 15, 2008. Female patient, 54 years of age, weighting 94.80 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, disease progression, dyspnoea, leukocytosis. Vidaza dosage: 76 MG/M2,X7 DAY, SUBCUTANEOUS. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient recovered.

Vidaza Side Effects Report #5912095-4
Vidaza side effect was reported by a Physician from AUSTRALIA on Sept 24, 2008. Female patient, 54 years of age, weighting 94.80 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, disease progression, escherichia sepsis, leukocytosis. Vidaza dosage: (76 MG/M2, X 7 DAY), SUBCUTANEOUS. During the same period patient was treated with THALIDOMIDE. Patient was hospitalized. Patient died on 09/20/2008.


Vidaza Side Effects Report #4811535-1
Vidaza side effect was reported by a Physician from POLAND on Oct 10, 2005. Female patient, 53 years of age, weighting 130.1 lb, was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: abdominal distension, acute pulmonary oedema, anaemia, asthenia, atrial fibrillation , blood glucose increased, cardiogenic shock, gastrointestinal haemorrhage. Vidaza dosage: 100 MG (DAILY X 7 DAYS), SUBCUTANEOUS. During the same period patient was treated with ENCORTON, POLPRAZOL, DIAPREL, HEMOROL, PROPRANOLOL, ENALAPRIL MALEATE, SPIRONOL, FLUCONAZOLE. Patient was hospitalized. Patient died on 10/03/2005.

Vidaza Side Effects Report #4638334-8
Vidaza side effect was reported by a Physician from on Apr 04, 2005. Female patient was diagnosed with myelodysplastic syndrome and was treated with Vidaza. After drug was administered, patient experienced the following side effects: acute pulmonary oedema, cardiac failure, cerebrovascular accident, condition aggravated, haemoglobin decreased, neutropenia, platelet count decreased, platelet count increased, pneumonia . Vidaza dosage: 150 MG ( 7 DAYS/MONTH), SUBCUTANEOUS. During the same period patient was treated with OFLOCET, AMPICILLIN. Patient was hospitalized. Patient died on 04/01/2005.